GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $83.84 $93.35 Friday, 19th Apr 2024 BMRN stock ended at $88.63. This is 1.60% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $88.29 to a day high of $90.18.
90 days $83.44 $94.51
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2023-10-19 $85.20 $85.28 $82.41 $82.59 900 033
2023-10-18 $85.93 $86.59 $85.07 $85.40 1 108 872
2023-10-17 $84.43 $87.12 $84.42 $86.67 1 172 553
2023-10-16 $86.10 $86.10 $84.35 $84.79 1 568 434
2023-10-13 $86.44 $87.50 $85.89 $86.34 495 157
2023-10-12 $88.68 $88.68 $85.64 $86.54 1 323 756
2023-10-11 $88.47 $89.00 $87.49 $88.58 814 203
2023-10-10 $87.15 $88.55 $86.89 $88.33 761 513
2023-10-09 $86.85 $87.49 $86.16 $87.03 785 060
2023-10-06 $87.06 $89.05 $86.98 $88.11 879 939
2023-10-05 $85.76 $87.54 $85.56 $87.29 936 806
2023-10-04 $86.33 $86.56 $85.15 $85.90 898 875
2023-10-03 $86.52 $87.55 $86.15 $86.19 1 085 833
2023-10-02 $88.35 $88.35 $85.86 $87.08 1 689 766
2023-09-29 $89.57 $89.92 $88.34 $88.48 1 510 042
2023-09-28 $89.54 $90.15 $88.43 $89.25 1 357 856
2023-09-27 $88.74 $90.77 $88.44 $90.37 1 897 711
2023-09-26 $87.17 $88.55 $86.92 $88.06 1 502 234
2023-09-25 $86.28 $87.39 $85.87 $87.04 1 092 657
2023-09-22 $86.28 $86.99 $85.76 $86.51 955 349
2023-09-21 $87.78 $88.21 $86.19 $86.27 980 461
2023-09-20 $88.72 $89.66 $87.98 $88.38 898 178
2023-09-19 $88.84 $89.59 $88.10 $88.82 1 025 208
2023-09-18 $88.07 $88.79 $87.91 $88.60 1 031 243
2023-09-15 $87.38 $89.14 $87.02 $88.16 1 392 904
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT